BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7966063)

  • 1. The clinical and research significance of the erythrocyte sedimentation rate.
    Wolfe F; Michaud K
    J Rheumatol; 1994 Jul; 21(7):1227-37. PubMed ID: 7966063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
    Sokka T; Pincus T
    J Rheumatol; 2003 Jun; 30(6):1138-46. PubMed ID: 12784382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis.
    Balsa A; Carmona L; González-Alvaro I; Belmonte MA; Tena X; Sanmartí R;
    J Rheumatol; 2004 Jan; 31(1):40-6. PubMed ID: 14705217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
    J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis.
    Sarban S; Kocyigit A; Yazar M; Isikan UE
    Clin Biochem; 2005 Nov; 38(11):981-6. PubMed ID: 16150434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
    Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
    Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis.
    Wong PK; Young L; Vaile JH; Tan L; Bertouch JV; Bleasel JF; White C
    Intern Med J; 2004; 34(9-10):539-44. PubMed ID: 15482266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
    Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
    J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are clinical trials in rheumatoid arthritis generalizable to routine practice? A re-evaluation of trial entry criteria.
    Kingsley GH; Khoshaba B; Smith CM; Choy EH; Scott DL
    Rheumatology (Oxford); 2005 May; 44(5):629-32. PubMed ID: 15705630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
    Wolfe F
    J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The level of inflammation in rheumatoid arthritis is determined early and remains stable over the longterm course of the illness.
    Wolfe F; Pincus T
    J Rheumatol; 2001 Aug; 28(8):1817-24. PubMed ID: 11508584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-reactive protein but not erythrocyte sedimentation rate is associated with clinical severity in patients with osteoarthritis of the knee or hip.
    Wolfe F
    J Rheumatol; 1997 Aug; 24(8):1486-8. PubMed ID: 9263139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
    Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS
    J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis.
    Radovits BJ; Fransen J; van Riel PL; Laan RF
    Ann Rheum Dis; 2008 Aug; 67(8):1127-31. PubMed ID: 17965425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
    Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
    J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation.
    Escalante A; Haas RW; del Rincón I
    Arch Intern Med; 2005 Jul; 165(14):1624-9. PubMed ID: 16043681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is fatigue an inflammatory variable in rheumatoid arthritis (RA)? Analyses of fatigue in RA, osteoarthritis, and fibromyalgia.
    Bergman MJ; Shahouri SH; Shaver TS; Anderson JD; Weidensaul DN; Busch RE; Wang S; Wolfe F
    J Rheumatol; 2009 Dec; 36(12):2788-94. PubMed ID: 19918042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.